Gili Regev-Yochay

BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study.

Rahav G, Lustig Y, Lavee J, Magen H, Hod T, Shmueli ES, Ben-Ari Z, Halperin R, Indenbaum V, Olmer L, Huppert A, Mor E, Regev-Yochay G, Cohen C, Finesod AW, Levy I.

EClinicalMedicine. 2021 Nov. 41:101158. PMID: 34693234

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.

Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, Doolman R, Asraf K, Mendelson E, Ziv A, Rubin C, Freedman L, Kreiss Y, Regev-Yochay G.

N Engl J Med. 2021 Oct 06. PMID: 34614326

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. Reply.

Amit S, Gonen T, Regev-Yochay G.

N Engl J Med. 2021 10 21. 385(17):1630-1631. PMID: 34587379

Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers.

Gilboa M, Tal I, Levin EG, Segal S, Belkin A, Zilberman-Daniels T, Biber A, Rubin C, Rahav G, Regev-Yochay G.

Infect Control Hosp Epidemiol. 2021 Sep 23. 1-6. PMID: 34551833

Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy.

Nir O, Schwartz A, Toussia-Cohen S, Leibovitch L, Strauss T, Asraf K, Doolman R, Sharabi S, Cohen C, Lustig Y, Regev-Yochay G, Yinon Y.

Am J Obstet Gynecol MFM. 2021 Sep 20. 4(1):100492. PMID: 34547533

Mobile phones and respiratory viral infections.

Melzer E, Regev-Yochay G.

J Infect Dis. 2021 Sep 18. PMID: 34536270

First Reported Nosocomial SARS-CoV-2 Outbreak in a Hospital-Based Laundry Facility.

Goldenfeld M, Zuckerman N, Amit S, Tal I, Hasson S, Gefen-Halevi S, Biber A, Mor O, Regev-Yochay G.

Epidemiol Infect. 2021 Sep 15. 1-17. PMID: 34521489

Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy - a single centre prospective study.

Shmueli ES, Itay A, Margalit O, Berger R, Halperin S, Jurkowicz M, Levin EG, Levy I, Olmer L, Regev-Yochay G, Lustig Y, Rahav G.

Eur J Cancer. 2021 11. 157:124-131. PMID: 34508994

Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.

Shavit R, Maoz-Segal R, Iancovici-Kidon M, Offengenden I, Haj Yahia S, Machnes Maayan D, Lifshitz-Tunitsky Y, Niznik S, Frizinsky S, Deutch M, Elbaz E, Genaim H, Rahav G, Levy I, Belkin A, Regev-Yochay G, Afek A, Agmon-Levin N.

JAMA Netw Open. 2021 08 02. 4(8):e2122255. PMID: 34463744

Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine.

Schwartz A, Nir O, Toussia-Cohen S, Leibovich L, Strauss T, Asraf K, Doolman R, Sharabi S, Cohen C, Levin EG, Lustig Y, Regev-Yochay G, Yinon Y.

Am J Obstet Gynecol. 2021 Nov. 225(5):577-579. PMID: 34352250